Hiscox PLC
26 October 2005
On 5 October 2005, the Board of Hiscox plc (the 'Company') exercised its
discretion to alter the terms of options over 562,481 ordinary shares of 5p
each, being all those subsisting options granted in 1998 under the Hiscox
Unapproved Share Option Scheme (the 'Scheme'). The effect of this alteration is
to extend the exercise period of those options by three years, as if they had
been granted with an expiry date of ten years from the date of grant.
Accordingly, these options will now expire on 19 October 2008 and will continue
to be exercisable at £1.62 each.
This extension brings options granted under the Scheme in line with all other
Hiscox plc executive share options schemes, and affects options held by
directors and Persons Discharging Managerial Responsibility as set out below:
Director No. of ordinary shares under option
R Childs 87,566
R Hiscox 71,147
B Masojada 71,147
Persons Discharging
Managerial Responsibility No. of ordinary shares under option
R Watson 65,674
C Dupplin 27,364
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.